Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-016-2199-z
Published Online: 2016-03-01
Published Print: 2016-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Woodfield, Sarah E.
Zhang, Linna
Scorsone, Kathleen A.
Liu, Yin
Zage, Peter E.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation